Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Somatostatin receptor 3 (SSTR3) is a G protein-coupled receptor that mediates the effects of somatostatin. It is involved in inhibiting hormone secretion, antiproliferative effects, and neuromodulation. SSTR3 is highly expressed in the brain (notably neuronal cilia), pancreatic islets, and anterior pituitary gland. It is targeted by endogenous peptides (somatostatins) and synthetic drugs to modulate hormone release or inhibit tumor growth.
Inhibition of adenylyl cyclase via Gi/o proteins; modulation of hormone release; inhibition of tumor growth
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Somatostatin receptor 3 (SSTR3).